Skip to content

Acral Melanoma Symptoms and Outlook: Understanding its Characteristics and Potential Results

Acral lentiginous melanoma symptoms and outlook

Acral Melanoma Symptoms and Outlook: An Overview
Acral Melanoma Symptoms and Outlook: An Overview

Acral Melanoma Symptoms and Outlook: Understanding its Characteristics and Potential Results

Acral Lentiginous Melanoma (ALM) is a type of skin cancer that frequently affects the palms, soles, and under the nails, and is more prevalent among African Americans and Asians.

### Symptoms of ALM

ALM often manifests as a dark line or streak beneath a toenail or fingernail, appearing as a black discoloration or a subtle, irregular patch of light brown-grey skin resembling a stain. Other symptoms include irregular dark areas on the soles of the feet or palms of the hands, and changes in an existing mole or new pigmented lesions that may not adhere to the traditional ABCDE rule for melanoma but can still exhibit asymmetry, border irregularity, colour variation, and evolving characteristics over time.

### Diagnosis

Diagnosis of ALM involves a physical examination focusing on suspicious lesions on palms, soles, and under nails. Dermatoscopy (skin surface microscopy) may be used to examine pigmented lesions more closely, and a biopsy of the lesion is crucial to confirm malignancy and determine melanoma subtype and thickness. Imaging studies may be conducted for staging if invasive melanoma is confirmed.

### Treatment

Surgical excision is the primary treatment for ALM, aiming to remove the melanoma with adequate margins. Advanced or metastatic cases may require immunotherapy, targeted therapy, or chemotherapy. Early detection and treatment are crucial to improve outcomes. Regular dermatological follow-ups and self-monitoring are recommended to detect recurrences or new lesions.

It's important to note that chemotherapy, while aiming to destroy cancer cells, can also affect healthy cells and may result in severe adverse effects. Patients should discuss their treatment plan, expected side effects, and options for dealing with adverse effects with their doctor. The Food and Drug Administration has approved the chemotherapy drug aldesleukin (Proleukin) for the treatment of ALM.

Given the occurrence of ALM in less sun-exposed areas, it's essential to pay close attention to persistent skin changes in these locations, particularly in African American populations who are more at risk.

  1. Acral Lentiginous Melanoma (ALM) is more prevalent among African Americans and Asians, making it essential for these populations to pay extra attention to persistent skin changes on palms, soles, and under nails.
  2. While science has made great strides in the detection and treatment of ALM, advanced or metastatic cases may require medical-conditions such as immunotherapy, targeted therapy, or chemotherapy like aldesleukin (Proleukin).
  3. Skin-care for health-and-wellness includes regular dermatological follow-ups to help catch melanoma early on, as changes in an existing mole or new pigmented lesions can still exhibit warning signs like asymmetry, border irregularity, color variation, and evolving characteristics over time, even if they do not adhere to the traditional ABCDE rule.
  4. It's important to be aware that while cancer treatments like chemotherapy aim to destroy cancer cells, they can also affect healthy cells, potentially resulting in severe adverse effects.
  5. Patients should discuss their treatment plan, expected side effects, and options for dealing with adverse effects with their doctor, as preventative measures and management techniques can significantly improve their quality of life during treatment.

Read also:

    Latest